Results 11 to 20 of about 189,601 (408)
Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients. [PDF]
PLoS ONE, 2018 BACKGROUND:Proton pump inhibitor use is associated with incident chronic kidney disease, chronic kidney disease progression and end-stage renal disease.
Hee Jeong Lee +8 more
doaj +2 more sources
Annals of Clinical Microbiology and Antimicrobials, 2018 Background All Helicobacter pylori-infected patients are recommended for eradication with an appropriate regimen in each geographic area. The choice of the therapy is somewhat dependent on the antimicrobial susceptibility.
Hiroki Tanabe +11 more
doaj +2 more sources
Safety of proton pump inhibitors [PDF]
Alimentary Pharmacology & Therapeutics, 2000 Helge L. Waldum +2 more
openalex +4 more sources
Proton pump inhibitor use: systematic review of global trends and practices
European Journal of Clinical Pharmacology, 2023 Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use.
L. Shanika +3 more
semanticscholar +1 more source
Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
JAMA pediatrics, 2023 This cohort study examines data from French national registers for children who received treatment for gastric acid–related disorders to determine the association between use of proton pump inhibitors and serious infections in this population.
Marion Lassalle +2 more
semanticscholar +1 more source
Mechanisms of proton pump inhibitor‐induced hypomagnesemia
Acta Physiologica, 2022 Proton pump inhibitors (PPIs) reliably suppress gastric acid secretion and are therefore the first‐line treatment for gastric acid‐related disorders. Hypomagnesemia (serum magnesium [Mg2+]
Lisanne M. M. Gommers +2 more
semanticscholar +1 more source
Critical Care Explorations, 2021 OBJECTIVES:. Histamine-2 receptor antagonists are commonly administered for stress ulcer prophylaxis in critically ill adults and may be associated with delirium development.
Ami Shiddapur, BS +3 more
doaj +1 more source
Journal of Gastroenterology and Hepatology, 2022 Potassium‐competitive acid blocker (PCAB) is a recent alternative to proton pump inhibitor (PPI) for potent acid suppression. The current systematic review and meta‐analysis aimed to compare the efficacy and safety of PCAB versus PPI in treating gastric ...
D. M. Simadibrata, A. Syam, Y. Lee
semanticscholar +1 more source
Regular proton pump inhibitor use and incident dementia: population-based cohort study
BMC Medicine, 2022 Background To examine the association between regular use of proton pump inhibitors and the risk of incident dementia, including dementia subtypes, and whether the association differs between APOE genotypes.
Peidong Zhang +9 more
doaj +1 more source
Adverse Effects Associated with Proton Pump Inhibitor Use
Cureus, 2021 Proton pump inhibitors (PPIs) marked a before and after in the management of gastric acid‐related disorders since their introduction to the market in 1989.
Marcel Yibirin +4 more
semanticscholar +1 more source